FRAN MILLER: Open Payments
NPI 1013196773 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,792 in 37 payments from 12 companies in 2025. Trend: 2023 $2,215 · 2024 $2,704 · 2025 $1,792
Food & beverage: $1,792
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $399 |
| AstraZeneca Pharmaceuticals LP | 5 | $362 |
| Amgen Inc. | 4 | $270 |
| Novo Nordisk Inc | 2 | $135 |
| PFIZER INC. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $122 |
| Lilly USA, LLC | 1 | $119 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| Dexcom, Inc. | 4 | $74 |
| Exact Sciences Corporation | 3 | $48 |
Products named: VRAYLAR, AIRSUPRA, OTEZLA, REPATHA, PREVNAR 20, QULIPTA, Ozempic, ZEPBOUND.
Industry payments across PA — which companies pay providers there.
